Wikipedia -WSS

Wikipedia

author：comprehensive 2025-09-27 22:46:58 - browse：968

Medicare generally pays far more for CAR-T drugs that are administered in outpatient departments than it does for inpatient care. Adobe

WASHINGTON — Hospitals for years have complained that Medicare pays so little for CAR-T cancer treatments that they sometimes lose money administering the incredibly expensive treatments. But that could soon change: if drug companies succeed in making the cancer treatments safer, hospitals could provide them more often in outpatient departments, where payment is higher.

CAR-T uses the body’s own immune system to kill cancerous cells. The procedure, regulated as a drug, involves taking T cells from a patient’s blood, adding chimeric antigen receptors (CAR) to the T cells that kill cancer, and injecting the CAR-T treatment back into the patient.

It’s worked wonders in many cancer patients who have run out of options. But right now it’s almost exclusively administered in hospitals, because the side effects can require aggressive treatments. In many cases, the CAR-T cells trigger immune reactions that can be life-threatening.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Be careful with at

WSS

After Optum profits sink, UnitedHealth makes changes

Senator probes 340B programs at Cleveland Clinic, Bon Secours

Would Medicare drug price negotiations stall in a shutdown?

Medicaid, Medicare dual

Data show record exodus of life scientists from academia

BMS, looking to build heart drug business, turns to AI for diagnosis

entertainment

Wikipedia

knowledge

FDA approval of Sarepta Duchenne genetic therapy gives me hope

How one patient went off dialysis — and others can too

Trump demands the U.S. pay no more for drugs than other countries … again

YouTube cracks down on misinformation on cancer treatment

Affirmative action in medical school literally saved lives

Sudafed saga points to U.S. issues with evaluating older drugs

George Santos makes 1st court appearance after pleading not guilty to 13 counts

After a drawn out lobbying fight, ARPA

Jerome Adams on the need for new antivirals for Covid

Hospitals are dialing back on venture capital investing

hotspot

Maui wildfire now ranks as the fifth

Address the ethical violations that led to 'Three Identical Strangers'

Hospitals are dialing back on venture capital investing

Surge in Apellis stock fueled by confidence in safety of its eye drug

FDA advisers vote against ALS treatment from BrainStorm

Intercept Pharmaceuticals sells itself for less than $1 billion

hotspot

Wikipedia

explore

knowledge